文献速递生殖医学母胎医学

单中心1114例胎儿与1391例新生儿中ICSI后染色体异常与精液参数的关系

Chromosomal abnormalities after ICSI in relation to semen parameters: results in 1114 fetuses and 1391 neonates from a single center.
PubMed 文献 · Hum Reprod · 2020-01-01

单中心研究分析2004年1月至2012年12月卵母细胞取出后持续ICSI妊娠,产前诊断1114例胎儿中异常核型41例(3.7%,95%CI 2.7-4.9%),产后采样1391例新生儿中异常核型14例(1.0%,95%CI 0.6-1.7%);父亲精子浓度<15百万/ml、<5百万/ml及总精子数<10百万与子代新发核型异常风险升高相关。

要点

  • ICSI子代产前异常核型41/1114(3.7%,95%CI 2.7-4.9%),其中新发36例(3.2%,95%CI 2.3-4.4)。
  • 未产前诊断的ICSI新生儿异常核型14/1391(1.0%,95%CI 0.6-1.7%),新发12例。
  • 父亲精子浓度<15百万/ml者子代新发核型异常AOR 2.10(95%CI 1.14-3.78)。

核心结论

  • ICSI子代产前和产后核型的新发染色体异常率高于一般人群,且与父亲精液参数相关。
  • 作者认为精子质量差的夫妇ICSI受孕后新发核型异常风险升高,支持继续就产前检测进行咨询。

研究设计与样本

  • 单中心报告ICSI受孕子代的产前绒毛膜取样和羊膜腔穿刺核型结果及产后血样核型结果。
  • 纳入2004年1月至2012年12月卵母细胞取出后持续妊娠并移植新鲜ICSI胚胎(使用射精或非射精精子,新鲜或冻融)者。
  • 排除冻融胚胎移植、卵子或精子捐赠、IVF、植入前遗传学检测和IVM后的妊娠。
  • 4816例持续ICSI妊娠中4267例有妊娠结局信息;22.3%妊娠行产前检测,诊断1114例胎儿;未行侵入性产前诊断的妊娠中29.4%获得产后核型,共采样1391例新生儿。

主要发现

  • 产前异常核型见于29例单胎和12例多胎(41/1114;3.7%;95%CI 2.7-4.9%):36例为新发(3.2%;95%CI 2.3-4.4),其中数目异常25例、性染色体异常6例、结构异常5例,另5例为遗传性。
  • 产后样本中异常核型14/1391(1.0%;95%CI 0.6-1.7%):12例为新发异常,2例为遗传性平衡核型。
  • 母体年龄与新发胎儿染色体异常无显著关联(OR 1.05;95%CI 0.96-1.15;P=0.24);合并产前和产后数据后,新发核型异常的风险随母体年龄增加(OR 1.11;95%CI 1.04-1.19)。
  • 父亲精子浓度<15百万/ml者子代新发染色体异常率更高(AOR 2.10;95%CI 1.14-3.78),精子浓度<5百万/ml者AOR 1.9(95%CI 1.05-3.45),总精子数<10百万者AOR 1.97(95%CI 1.04-3.74)。
  • 除一例外,产前异常核型胎儿均使用射精精子行ICSI受孕;14例产后异常核型均见于使用射精精子行ICSI后的儿童。

关键数值与推荐

  • 正常精液质量定义采用世界卫生组织人类精液特征参考值。
  • 采用逻辑回归分析染色体异常患病率与母体年龄及精液质量的关系。

临床怎么用

  • 作者认为精子质量差的夫妇ICSI受孕后新发核型异常风险升高,支持继续就产前检测进行咨询。
  • 作者指出当前广泛使用的创新无创产前检测将产生更大数据集,有助于更均衡地估计ICSI子代核型异常患病率。

局限性

  • 无法排除ICSI子代核型异常患病率高于文献一般人群数据是ART后加强监测所致,因缺乏对照组。
  • 尽管未发现使用非射精精子行ICSI后更多染色体异常,但例数少,不能得出确切结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there a relationship between karyotype abnormalities in fetuses and children conceived by ICSI and their father's semen parameters? SUMMARY ANSWER: The de novo chromosomal abnormality rate in pre- and postnatal karyotypes of ICSI offspring was higher than in the general population and related to fathers' sperm parameters. WHAT IS KNOWN ALREADY: Several studies have reported a higher rate of de novo chromosomal anomalies in ICSI fetuses but recent data from large cohorts are limited. Overall, reported prevalences of non-inherited karyotype aberrations are increased in fetuses conceived after ICSI and vary between 1.6% and 4.2%. Only a few studies focus on the relation between karyotype anomalies in ICSI offspring and semen parameters of their fathers. Furthermore, an increased incidence of abnormal karyotypes in ICSI neonates has been described, but the rates vary widely across studies. STUDY DESIGN, SIZE, DURATION: We report on karyotype results from prenatal testing by means of chorionic villus sampling and amniocentesis and results from postnatal blood sampling in offspring conceived by ICSI in a single center. Ongoing pregnancies resulting from an oocyte retrieval between January 2004 and December 2012 and after transfer of fresh ICSI embryos obtained using ejaculated or non-ejaculated sperm (fresh or frozen-thawed) were considered. Pregnancies following frozen embryo transfer, oocyte or sperm donation, IVF, preimplantation genetic testing and IVM were excluded. All abnormal prenatal results after sampling are reported irrespective of the outcome of the pregnancy. PARTICIPANTS/MATERIALS, SETTING, METHODS: From the 4816 ongoing ICSI pregnancies, information on pregnancy outcome was available for 4267 pregnancies. Prenatal testing was performed in 22.3% of the pregnancies, resulting in a diagnosis in 1114 fetuses. A postnatal karyotype was obtained in 29.4% of the pregnancies in which no invasive prenatal diagnosis was performed, resulting in a total of 1391 neonates sampled. The prevalence of chromosomal anomalies according to maternal age and semen quality was analyzed with logistic regression. For definitions of normal semen quality, the World Health Organization reference values for human semen characteristics were adopted. MAIN RESULTS AND THE ROLE OF CHANCE: An abnormal fetal karyotype was found in 29 singletons and 12 multiples (41/1114; 3.7%; 95% CI 2.7-4.9%): 36 anomalies were de novo (3.2%; 95% CI 2.3-4.4), either numerical (n = 25), sex (n = 6) or structural (n = 5), and five were inherited. Logistic regression analysis did not show a significant association between maternal age and a de novo chromosomal fetal abnormality (odds ratio (OR) 1.05; 95% CI 0.96-1.15; P = 0.24). In all but one case, fetuses with an abnormal karyotype were conceived by ICSI using ejaculated sperm.Abnormal karyotypes were found in 14 (1.0%; 95% CI 0.6-1.7) out of 1391 postnatal samples of children born after ICSI who were not tested prenatally: 12 were de novo anomalies and two were inherited balanced karyotypes. The 14 abnormal karyotypes were all found in children born after ICSI using ejaculated sperm.The odds of a de novo karyotype aberration increased with maternal age when combining pre- and postnatal data (OR 1.11; 95% CI 1.04-1.19). A higher rate of de novo chromosomal abnormalities was found in fetuses and children of couples with men having a sperm concentration <15 million/ml (adjusted OR (AOR) 2.10; 95% CI 1.14-3.78), sperm concentration <5 million/ml (AOR 1.9; 95% CI 1.05-3.45) and total sperm count <10 million (AOR 1.97; 95% CI 1.04-3.74). LIMITATIONS, REASONS FOR CAUTION: We cannot exclude that the observation of a higher prevalence of karyotype anomalies in ICSI offspring compared to literature data in the general population is due to enhanced surveillance after ART given the lack of a control group. Although we did not find more chromosomal anomalies after ICSI with non-ejaculated sperm, the small numbers do not allow firm conclusions. WIDER IMPLICATIONS OF THE FINDINGS: The observed increased risk of a de novo karyotype anomaly after ICSI conception in couples with poor sperm warrants continued counseling toward prenatal testing.The current and widespread use of innovative non-invasive prenatal testing will result in larger datasets, adding to a balanced estimation of the prevalence of karyotype anomalies in ICSI offspring. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Methusalem grants issued by the Vrije Universiteit Brussel. All authors declared no conflict of interest related to this study. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Belva F, Bonduelle M, Buysse A, et al. Chromosomal abnormalities after ICSI in relation to semen parameters: results in 1114 fetuses and 1391 neonates from a single center. Hum Reprod. 2020. PMID: 32772109. doi:10.1093/humrep/deaa162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。